0001209191-15-077834.txt : 20151102
0001209191-15-077834.hdr.sgml : 20151102
20151102170801
ACCESSION NUMBER: 0001209191-15-077834
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151102
FILED AS OF DATE: 20151102
DATE AS OF CHANGE: 20151102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Steris plc
CENTRAL INDEX KEY: 0001624899
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 981203539
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: CHANCERY HOUSE, 190 WATERSIDE ROAD
STREET 2: HAMILTON INDUSTRIAL PARK
CITY: LEICESTER
STATE: X0
ZIP: LE5 1QZ
BUSINESS PHONE: (440) 354-2600
MAIL ADDRESS:
STREET 1: CHANCERY HOUSE, 190 WATERSIDE ROAD
STREET 2: HAMILTON INDUSTRIAL PARK
CITY: LEICESTER
STATE: X0
ZIP: LE5 1QZ
FORMER COMPANY:
FORMER CONFORMED NAME: New STERIS Ltd
DATE OF NAME CHANGE: 20141125
FORMER COMPANY:
FORMER CONFORMED NAME: Solar New HoldCo Ltd
DATE OF NAME CHANGE: 20141112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khan Gulam Amjad
CENTRAL INDEX KEY: 0001651656
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37614
FILM NUMBER: 151191379
MAIL ADDRESS:
STREET 1: 5960 HEISLEY ROAD
CITY: MENTOR
STATE: OH
ZIP: 44060
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-02
0
0001624899
Steris plc
STE
0001651656
Khan Gulam Amjad
C/O CHANCERY HOUSE, 190 WATERSIDE ROAD
HAMILTON INDUSTRIAL PARK
LEICESTER
X0
LE5 1QZ
UNITED KINGDOM
0
1
0
0
Sr. V.P., Procedural Solutions
Ordinary Shares, ?0.10 Nominal Value
2015-11-02
4
A
0
7000
A
7000
D
Employee Stock Option (right to buy)
65.05
2015-11-02
4
A
0
11700
A
2025-08-27
Ordinary Shares, ?0.10 Nominal Value
11700
11700
D
All 7,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019.
Represents ordinary shares of STERIS plc ("New STERIS") acquired pursuant to merger of a wholly-owned subsidiary of New STERIS with and into STERIS Corporation ("STERIS"), with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for common shares of STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received in the Merger in exchange for an option to purchase 11,700 STERIS common shares for $65.05 per share, subject to the same terms and conditions as the original STERIS stock option.
/s/ Dennis P. Patton, Authorized Representative under Power of Attorney
2015-11-02